CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Modular chimeric cytokine receptors with leucine zippers enhance the antitumour activity of CAR T cells via JAK/STAT signalling.
Modular chimeric cytokine receptors with leucine zippers enhance the antitumour activity of CAR T cells via JAK/STAT signalling.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
实体瘤中细胞因子供应不足,限制了嵌合抗原受体(CAR)T细胞抗肿瘤活性的维持。可通过转基因表达或在肿瘤内注射细胞因子,或通过工程化活化相应细胞因子受体,启动CAR-T 细胞中的细胞因子受体信号通路。然而,这些策略受到多重限制,包括旁观者细胞活化所致毒性、细胞因子体内分布不佳及相应受体下调。本研究显示,将T细胞中异二聚体细胞因子受体的胞外结构域替换为两个亮氨酸拉链基序,可实现最佳Janus激酶/信号转导及转录激活因子(JAK/STAT)信号传导。此类嵌合细胞因子受体可应用于常见γ链受体、白细胞介素10受体及白细胞介素12受体,使T细胞在缺乏细胞因子时仍可存活,而不会诱导自主性细胞生长;同时,在体外慢性抗原暴露条件下及小鼠人肿瘤异种移植模型中,均可增强CAR-T 细胞效应功能。作为模块化设计,亮氨酸拉链可用于在效应免疫细胞中构建持续活化的细胞因子受体。
The limited availability of cytokines in solid tumours hinders maintenance of the antitumour activity of chimeric antigen receptor (CAR) T cells. Cytokine receptor signalling pathways in CAR T cells can be activated by transgenic expression or injection of cytokines in the tumour, or by engineering the activation of cognate cytokine receptors.
However, these strategies are constrained by toxicity arising from the activation of bystander cells, by the suboptimal biodistribution of the cytokines and by downregulation of the cognate receptor.
Here we show that replacement of the extracellular domains of heterodimeric cytokine receptors in T cells with two leucine zipper motifs provides optimal Janus kinase/signal transducer and activator of transcription signalling.
Such chimeric cytokine receptors, which can be generated for common -chain receptors, interleukin-10 and -12 receptors, enabled T cells to survive cytokine starvation without induction of autonomous cell growth, and augmented the effector function of CAR T cells in vitro in the setting of chronic antigen exposure and in human tumour xenografts in mice. As a modular design, leucine zippers can be used to generate constitutively active cytokine receptors in effector immune cells.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。